{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:47:51Z","timestamp":1790729271331,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006314","name":"Biogen Idec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006314","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1111\/jth.15805","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T02:58:20Z","timestamp":1656557900000},"page":"2022-2034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Results of genetic analysis of 11\u2009341 participants enrolled in the My Life, Our Future hemophilia genotyping initiative in the United States"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2279-2550","authenticated-orcid":false,"given":"Jill M.","family":"Johnsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9900-7725","authenticated-orcid":false,"given":"Shelley N.","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9534-2067","authenticated-orcid":false,"given":"Angela","family":"Dove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7061-0272","authenticated-orcid":false,"given":"Haley","family":"McCracken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9661-014X","authenticated-orcid":false,"given":"Beth K.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9278-5471","authenticated-orcid":false,"given":"Martin","family":"Kircher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4660-542X","authenticated-orcid":false,"given":"Neil C.","family":"Josephson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1516-1865","authenticated-orcid":false,"given":"Jay","family":"Shendure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8456-066X","authenticated-orcid":false,"given":"Sarah E.","family":"Ruuska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7927-6418","authenticated-orcid":false,"given":"Leonard A.","family":"Valentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3310-328X","authenticated-orcid":false,"given":"Glenn F.","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5940-8217","authenticated-orcid":false,"given":"Crystal","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7399-3558","authenticated-orcid":false,"given":"Dunlei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2805-1016","authenticated-orcid":false,"given":"Michael","family":"Recht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3959-8797","authenticated-orcid":false,"given":"Barbara A.","family":"Konkle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.15805_bb0010","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1365-2141.2010.08545.x","article-title":"Guideline on the management of haemophilia in the fetus and neonate","volume":"154","author":"Chalmers","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.15805_bb0015","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1182\/blood-2011-09-379453","article-title":"F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta\u2010analysis","volume":"119","author":"Gouw","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.15805_bb0020","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1182\/blood-2013-02-483263","article-title":"Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A","volume":"122","author":"Eckhardt","year":"2013","journal-title":"Blood"},{"issue":"Suppl 6","key":"10.1111\/jth.15805_bb0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2516.2006.01361.x","article-title":"Genetic risk factors for inhibitors to factors VIII and IX","volume":"12","author":"Oldenburg","year":"2006","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15805_bb0030","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2141.2007.06657.x","article-title":"Inhibitor development in haemophilia B: an orphan disease in need of attention","volume":"138","author":"DiMichele","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.15805_bb0035","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1182\/blood-2012-11-469403","article-title":"Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A","volume":"121","author":"Carcao","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.15805_bb0040","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1182\/asheducation-2015.1.152","article-title":"Using genetic diagnostics in hemophilia and von Willebrand disease","volume":"2015","author":"Swystun","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1111\/jth.15805_bb0045","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1182\/blood-2005-03-1307","article-title":"Aminoglycoside suppression of nonsense mutations in severe hemophilia","volume":"106","author":"James","year":"2005","journal-title":"Blood"},{"key":"10.1111\/jth.15805_bb0050","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev-med-012017-043332","article-title":"Entering the modern era of gene therapy","volume":"70","author":"Anguela","year":"2019","journal-title":"Annu Rev Med"},{"key":"10.1111\/jth.15805_bb0055","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood.2019000790","article-title":"CRISPR\/Cas9\u2010mediated in vivo gene targeting corrects hemostasis in newborn and adult factor IX\u2010knockout mice","volume":"133","author":"Wang","year":"2019","journal-title":"Blood"},{"key":"10.1111\/jth.15805_bb0060","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1182\/bloodadvances.2016002923","article-title":"Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life Our Future initiative","volume":"1","author":"Johnsen","year":"2017","journal-title":"Blood Adv"},{"key":"10.1111\/jth.15805_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007956","article-title":"HemoMIPs\u2014automated analysis and result reporting pipeline for targeted sequencing data","volume":"16","author":"Kleinert","year":"2020","journal-title":"PLoS Comput Biol"},{"key":"10.1111\/jth.15805_bb0070","first-page":"310","article-title":"A general framework for estimating the relative pathogenicity of human genetic variants","volume":"46","author":"Kircher","year":"2014","journal-title":"NatGenet"},{"key":"10.1111\/jth.15805_bb0075","unstructured":"European Association for Haemophilia and Allied Disorders (EAHAD) Coagulation Factor VIII Variant Database. www.factorviii\u2010db.org. Accessed August 31, 2021."},{"key":"10.1111\/jth.15805_bb0080","unstructured":"European Association for Haemophilia and Allied Disorders (EAHAD) Coagulation Factor IX Variant Database. www.factorix.org. Accessed August 31, 2021."},{"key":"10.1111\/jth.15805_bb0085","unstructured":"Centers for Disease Control and Prevention (CDC) Hemophilia A Mutation Project (CHAMP). http:\/\/www.cdc.gov\/ncbddd\/hemophilia\/champs.html. Accessed August 31, 2021."},{"key":"10.1111\/jth.15805_bb0090","unstructured":"Centers for Disease Control and Prevention (CDC) Hemophilia B Mutation Project (CHBMP). http:\/\/www.cdc.gov\/ncbddd\/hemophilia\/champs.html. Accessed August 31, 2021."},{"key":"10.1111\/jth.15805_bb0095","unstructured":"Hemobase. www.hemobase.com. Accessed August 31, 2021."},{"key":"10.1111\/jth.15805_bb0100","unstructured":"Centers for Disease Control and Prevention Community Counts Hemophilia Treatment Center Population Profile. https:\/\/www.cdc.gov\/ncbddd\/hemophilia\/communitycounts\/data\u2010reports\/2020\u20103\/index.html. Accessed August 31, 2021."},{"key":"10.1111\/jth.15805_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6905a1","article-title":"Evaluation of CDC's Hemophilia Surveillance Program \u2013 universal data collection (1998\u20132011) and community counts (2011\u20132019), United States","volume":"69","author":"Schieve","year":"2020","journal-title":"MMWR Surveill Summ"},{"key":"10.1111\/jth.15805_bb0110","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"10.1111\/jth.15805_bb0115","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1177\/00131640021970871","article-title":"Type I error rate comparisons of post hoc procedures for I j chi\u2010square tables","volume":"60","author":"MacDonald","year":"2000","journal-title":"Educ Psychol Meas"},{"key":"10.1111\/jth.15805_bb0120","unstructured":"European Association for Haemophilia and Allied Disorders (EAHAD) Coagulation Factor Variant Databases. https:\/\/dbs.eahad.org\/. Accessed August 31, 2021."},{"key":"10.1111\/jth.15805_bb0125","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/hae.13947","article-title":"The European Association for Haemophilia and Allied Disorders (EAHAD) Coagulation Factor Variant Databases: important resources for haemostasis clinicians and researchers","volume":"26","author":"McVey","year":"2020","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15805_bb0130","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/GIM.0b013e3182217a3a","article-title":"American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants","volume":"13","author":"Kearney","year":"2011","journal-title":"Genet Med"},{"key":"10.1111\/jth.15805_bb0135","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/hae.13998","article-title":"Occurrence rates of haemophilia among males in the United States based on surveillance conducted in specialized haemophilia treatment centres","volume":"26","author":"Soucie","year":"2020","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15805_bb0140","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/jth.12902","article-title":"Evaluation of von Willebrand factor phenotypes and genotypes in hemophilia A patients with and without identified F8 mutations","volume":"13","author":"Boylan","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15805_bb0145","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ajh.24777","article-title":"Acquired hemophilia A: Updated review of evidence and treatment guidance","volume":"92","author":"Kruse\u2010Jarres","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.15805_bb0150","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/hae.13587","article-title":"Postanalytical considerations that may improve the diagnosis or exclusion of haemophilia and von Willebrand disease","volume":"24","author":"Favaloro","year":"2018","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15805_bb0155","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1055\/s-0033-1349223","article-title":"Combined deficiency of coagulation factors V and VIII: an update","volume":"39","author":"Zheng","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.15805_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020240","article-title":"GGCX\u2010associated phenotypes: an overview in search of genotype\u2010phenotype correlations","volume":"18","author":"De Vilder","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1111\/jth.15805_bb0165","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3324\/haematol.12427","article-title":"The Italian AICE\u2010genetics hemophilia A database: results and correlation with clinical phenotype","volume":"93","author":"Margaglione","year":"2008","journal-title":"Haematologica"},{"key":"10.1111\/jth.15805_bb0170","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/ajh.23557","article-title":"The Canadian \u201cNational Program for hemophilia mutation testing\u201d database: a ten\u2010year review","volume":"88","author":"Rydz","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.15805_bb0175","first-page":"392","article-title":"Haemophilia A: the consequences of de novo mutations. Two case reports","volume":"16","author":"Zarrilli","year":"2018","journal-title":"Blood Transfus"},{"key":"10.1111\/jth.15805_bb0180","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.thromres.2020.05.041","article-title":"Six molecular patterns leading to hemophilia A phenotype in 18 females from Poland","volume":"193","author":"Janczar","year":"2020","journal-title":"Thromb Res"},{"key":"10.1111\/jth.15805_bb0185","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2516.2011.02700.x","article-title":"F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race\/ethnicity","volume":"18","author":"Miller","year":"2012","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15805_bb0190","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/hae.12229","article-title":"Prevalent inhibitors in haemophilia B subjects enrolled in the Universal Data Collection database","volume":"20","author":"Puetz","year":"2014","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15805_bb0195","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1111\/j.1365-2516.2011.02739.x","article-title":"Increased prevalence of inhibitors in Hispanic patients with severe haemophilia A enrolled in the Universal Data Collection database","volume":"18","author":"Carpenter","year":"2012","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15805_bb0200","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1365-2516.2011.02509.x","article-title":"Assessing the impact of age, race, ethnicity and inhibitor status on functional limitations of patients with severe and moderately severe haemophilia A","volume":"17","author":"Leissinger","year":"2011","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15805_bb0205","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1365-2516.2001.00510.x","article-title":"The Malm\u00f6 International Brother Study (MIBS): further support for genetic predisposition to inhibitor development in hemophilia patients","volume":"7","author":"Astermark","year":"2001","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15805_bb0210","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1365-2516.2009.02058.x","article-title":"Risk factors for inhibitor formation in haemophilia: a prevalent case\u2010control study","volume":"15","author":"Ragni","year":"2009","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15805_bb0215","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2516.1999.00300.x","article-title":"Incidence of inhibitors in haemophilia A patients \u2013 a review of recent studies of recombinant and plasma\u2010derived factor VIII concentrates","volume":"5","author":"Scharrer","year":"1999","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15805_bb0220","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12881-015-0157-2","article-title":"Clinical characterization of int22h1\/int22h2\u2010mediated Xq28 duplication\/deletion: new cases and literature review","volume":"16","author":"El\u2010Hattab","year":"2015","journal-title":"BMC Med Genet"},{"key":"10.1111\/jth.15805_bb0225","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1160\/TH17-01-0046","article-title":"Complex recombination with deletion in the F8 and duplication in the TMLHE mediated by int22h copies during early embryogenesis","volume":"117","author":"Chen","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.15805_bb0230","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3324\/haematol.2019.239160","article-title":"Inhibitor incidence in an unselected cohort of previously untreated patients with severe haemophilia B: a PedNet study","volume":"106","author":"Male","year":"2021","journal-title":"Haematologica"},{"key":"10.1111\/jth.15805_bb0235","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/hae.12854","article-title":"Mutation analysis of Swedish haemophilia B families \u2013 high frequency of unique mutations","volume":"22","author":"M\u00e5rtensson","year":"2016","journal-title":"Haemophilia"},{"key":"10.1111\/jth.15805_bb0240","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1182\/blood-2006-06-026104","article-title":"A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels","volume":"109","author":"Viel","year":"2007","journal-title":"Blood"},{"key":"10.1111\/jth.15805_bb0245","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1111\/jth.13144","article-title":"Complexity and diversity of F8 genetic variations in the 1000 genomes","volume":"13","author":"Li","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15805_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2016.04.005","article-title":"Principles of genetic variations and molecular diseases: applications in hemophilia A","volume":"104","author":"Lannoy","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1111\/jth.15805_bb0255","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1111\/jth.15805_bb0260","unstructured":"Coagulation Factor Deficiency Variant Curation Expert Panel. Clinical Genome Resource (ClinGen); 2020."},{"key":"10.1111\/jth.15805_bb0265","unstructured":"NHLBI Trans\u2010Omics for Precision Medicine. https:\/\/www.nhlbiwgs.org."},{"key":"10.1111\/jth.15805_bb0270","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2105\/AJPH.2016.303578","article-title":"Transgender population size in the United States: a meta\u2010regression of population\u2010based probability samples","volume":"107","author":"Meerwijk","year":"2017","journal-title":"Am J Public Health"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15805","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.15805","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622021146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622021146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15805","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:36:09Z","timestamp":1761536169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622021146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1538783622021146"],"URL":"https:\/\/doi.org\/10.1111\/jth.15805","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Results of genetic analysis of 11\u2009341 participants enrolled in the My Life, Our Future hemophilia genotyping initiative in the United States","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.15805","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}